vs

Side-by-side financial comparison of AXIS CAPITAL HOLDINGS LTD (AXS) and Zimmer Biomet (ZBH). Click either name above to swap in a different company.

Zimmer Biomet is the larger business by last-quarter revenue ($2.1B vs $1.6B, roughly 1.3× AXIS CAPITAL HOLDINGS LTD). AXIS CAPITAL HOLDINGS LTD runs the higher net margin — 15.5% vs 11.4%, a 4.1% gap on every dollar of revenue. On growth, Zimmer Biomet posted the faster year-over-year revenue change (9.3% vs 8.0%). Over the past eight quarters, AXIS CAPITAL HOLDINGS LTD's revenue compounded faster (6.4% CAGR vs 3.7%).

AXIS Capital Holdings Limited is the holding company for AXIS group of companies. It offers various risk transfer products and services through subsidiaries and branch networks in Bermuda, the United States, Canada, Europe and Singapore. The company offers insurance services including property, professional lines, terrorism, marine, energy, environmental and other insurance. The reinsurance services include property, professional lines, credit and bond, and others.

Zimmer Biomet Holdings, Inc. is a publicly traded American medical device company. It was founded in 1927 to produce aluminum splints. The firm is headquartered in Warsaw, Indiana, where it is part of the medical devices business cluster.

AXS vs ZBH — Head-to-Head

Bigger by revenue
ZBH
ZBH
1.3× larger
ZBH
$2.1B
$1.6B
AXS
Growing faster (revenue YoY)
ZBH
ZBH
+1.3% gap
ZBH
9.3%
8.0%
AXS
Higher net margin
AXS
AXS
4.1% more per $
AXS
15.5%
11.4%
ZBH
Faster 2-yr revenue CAGR
AXS
AXS
Annualised
AXS
6.4%
3.7%
ZBH

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
AXS
AXS
ZBH
ZBH
Revenue
$1.6B
$2.1B
Net Profit
$254.8M
$238.3M
Gross Margin
64.6%
Operating Margin
15.6%
17.9%
Net Margin
15.5%
11.4%
Revenue YoY
8.0%
9.3%
Net Profit YoY
31.3%
30.5%
EPS (diluted)
$1.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AXS
AXS
ZBH
ZBH
Q1 26
$1.6B
$2.1B
Q4 25
$1.7B
$2.2B
Q3 25
$1.7B
$2.0B
Q2 25
$1.6B
$2.1B
Q1 25
$1.5B
$1.9B
Q4 24
$1.5B
$2.0B
Q3 24
$1.6B
$1.8B
Q2 24
$1.5B
$1.9B
Net Profit
AXS
AXS
ZBH
ZBH
Q1 26
$254.8M
$238.3M
Q4 25
$289.6M
$139.4M
Q3 25
$301.9M
$230.9M
Q2 25
$223.4M
$152.8M
Q1 25
$194.1M
$182.0M
Q4 24
$293.6M
$239.5M
Q3 24
$180.7M
$249.1M
Q2 24
$212.0M
$242.8M
Gross Margin
AXS
AXS
ZBH
ZBH
Q1 26
64.6%
Q4 25
64.7%
Q3 25
72.1%
Q2 25
71.5%
Q1 25
71.2%
Q4 24
71.0%
Q3 24
70.5%
Q2 24
71.5%
Operating Margin
AXS
AXS
ZBH
ZBH
Q1 26
15.6%
17.9%
Q4 25
19.0%
6.9%
Q3 25
22.1%
17.6%
Q2 25
17.2%
14.4%
Q1 25
15.5%
15.3%
Q4 24
18.6%
19.2%
Q3 24
14.2%
15.3%
Q2 24
17.4%
18.1%
Net Margin
AXS
AXS
ZBH
ZBH
Q1 26
15.5%
11.4%
Q4 25
16.7%
6.2%
Q3 25
18.0%
11.5%
Q2 25
13.7%
7.4%
Q1 25
12.8%
9.5%
Q4 24
20.0%
11.8%
Q3 24
11.2%
13.7%
Q2 24
14.6%
12.5%
EPS (diluted)
AXS
AXS
ZBH
ZBH
Q1 26
$1.22
Q4 25
$3.63
$0.71
Q3 25
$3.74
$1.16
Q2 25
$2.72
$0.77
Q1 25
$2.26
$0.91
Q4 24
$3.38
$1.18
Q3 24
$2.04
$1.23
Q2 24
$2.40
$1.18

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AXS
AXS
ZBH
ZBH
Cash + ST InvestmentsLiquidity on hand
$862.5M
$424.2M
Total DebtLower is stronger
$7.5B
Stockholders' EquityBook value
$6.4B
$12.7B
Total Assets
$35.6B
$22.7B
Debt / EquityLower = less leverage
0.59×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AXS
AXS
ZBH
ZBH
Q1 26
$862.5M
$424.2M
Q4 25
$820.3M
$591.9M
Q3 25
$825.9M
$1.3B
Q2 25
$852.1M
$556.9M
Q1 25
$2.8B
$1.4B
Q4 24
$2.1B
$525.5M
Q3 24
$981.0M
$569.0M
Q2 24
$1.1B
$420.1M
Total Debt
AXS
AXS
ZBH
ZBH
Q1 26
$7.5B
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Stockholders' Equity
AXS
AXS
ZBH
ZBH
Q1 26
$6.4B
$12.7B
Q4 25
$6.4B
$12.7B
Q3 25
$6.4B
$12.8B
Q2 25
$6.2B
$12.5B
Q1 25
$5.9B
$12.4B
Q4 24
$6.1B
$12.5B
Q3 24
$6.1B
$12.4B
Q2 24
$5.7B
$12.7B
Total Assets
AXS
AXS
ZBH
ZBH
Q1 26
$35.6B
$22.7B
Q4 25
$34.5B
$23.1B
Q3 25
$34.3B
$23.5B
Q2 25
$34.2B
$22.9B
Q1 25
$33.2B
$22.2B
Q4 24
$32.5B
$21.4B
Q3 24
$32.7B
$21.7B
Q2 24
$32.1B
$21.5B
Debt / Equity
AXS
AXS
ZBH
ZBH
Q1 26
0.59×
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AXS
AXS
ZBH
ZBH
Operating Cash FlowLast quarter
$359.4M
Free Cash FlowOCF − Capex
$245.9M
FCF MarginFCF / Revenue
11.8%
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
1.51×
TTM Free Cash FlowTrailing 4 quarters
$1.4B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AXS
AXS
ZBH
ZBH
Q1 26
$359.4M
Q4 25
$630.4M
$517.4M
Q3 25
$673.8M
$418.7M
Q2 25
$-1.7B
$378.2M
Q1 25
$309.1M
$382.8M
Q4 24
$355.5M
$506.3M
Q3 24
$587.0M
$395.7M
Q2 24
$518.1M
$369.4M
Free Cash Flow
AXS
AXS
ZBH
ZBH
Q1 26
$245.9M
Q4 25
$442.6M
Q3 25
$363.7M
Q2 25
$328.1M
Q1 25
$338.2M
Q4 24
$454.8M
Q3 24
$351.2M
Q2 24
$316.7M
FCF Margin
AXS
AXS
ZBH
ZBH
Q1 26
11.8%
Q4 25
19.7%
Q3 25
18.2%
Q2 25
15.8%
Q1 25
17.7%
Q4 24
22.5%
Q3 24
19.3%
Q2 24
16.3%
Capex Intensity
AXS
AXS
ZBH
ZBH
Q1 26
Q4 25
3.3%
Q3 25
2.7%
Q2 25
2.4%
Q1 25
2.3%
Q4 24
2.5%
Q3 24
2.4%
Q2 24
2.7%
Cash Conversion
AXS
AXS
ZBH
ZBH
Q1 26
1.51×
Q4 25
2.18×
3.71×
Q3 25
2.23×
1.81×
Q2 25
-7.41×
2.48×
Q1 25
1.59×
2.10×
Q4 24
1.21×
2.11×
Q3 24
3.25×
1.59×
Q2 24
2.44×
1.52×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons